Observational study on off-label use of tocilizumab in patients with severe COVID-19 | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Original research

Observational study on off-label use of tocilizumab in patients with severe COVID-19

Online download statistics by month:

Online download statistics by month: September 2020 to March 2024

	Abstract	Full	Pdf
Sep 2020	1032	964	152
Oct 2020	326	324	46
Nov 2020	286	281	62
Dec 2020	265	257	57
Jan 2021	500	499	81
Feb 2021	362	347	61
Mar 2021	170	152	51
Apr 2021	146	137	36
May 2021	175	166	46
Jun 2021	114	106	38
Jul 2021	112	110	50
Aug 2021	103	101	31
Sep 2021	112	107	34
Oct 2021	138	134	60
Nov 2021	98	92	31
Dec 2021	72	68	21
Jan 2022	78	75	28
Feb 2022	57	55	19
Mar 2022	82	77	20
Apr 2022	70	68	16
May 2022	67	69	22
Jun 2022	59	58	24
Jul 2022	49	48	19
Aug 2022	83	50	12
Sep 2022	58	54	16
Oct 2022	82	75	7
Nov 2022	35	36	11
Dec 2022	52	52	15
Jan 2023	49	49	16
Feb 2023	55	57	8
Mar 2023	53	51	30
Apr 2023	109	3	6
May 2023	62	1	1
Jun 2023	67	1	1
Jul 2023	62	4	1
Aug 2023	50	0	0
Sep 2023	39	1	0
Oct 2023	74	0	2
Nov 2023	63	3	1
Dec 2023	70	1	1
Jan 2024	55	3	1
Feb 2024	78	6	0
Mar 2024	49	3	2
Total	5718	4745	1136